Mepolizumab yields lower rate of moderate/severe exacerbations in COPD

Published Date: 13 May 2025

For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

2.

Cancer Patients' Depression May Be Helped by Psilocybin.

3.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

4.

Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection

5.

Providing essential cancer care to rural communities


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot